Tissue engineering a fetal membrane by Mi, Shengli et al.
Tissue Engineering a Fetal Membrane
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The aim of this study was to construct an artificial fetal membrane (FM) by combination of human amniotic
epithelial stem cells (hAESCs) and a mechanically enhanced collagen scaffold containing encapsulated human
amniotic stromal fibroblasts (hASFs). Such a tissue-engineered FM may have the potential to plug structural
defects in the amniotic sac after antenatal interventions, or to prevent preterm premature rupture of the FM. The
hAESCs and hASFs were isolated from human fetal amniotic membrane (AM). Magnetic cell sorting was used to
enrich the hAESCs by positive ATP-binding cassette G2 selection. We investigated the use of a laminin/fibro-
nectin (1:1)-coated compressed collagen gel as a novel scaffold to support the growth of hAESCs. A type I
collagen gel was dehydrated to form a material mimicking the mechanical properties and ultra-structure of
human AM. hAESCs successfully adhered to and formed a monolayer upon the biomimetic collagen scaffold.
The resulting artificial membrane shared a high degree of similarity in cell morphology, protein expression
profiles, and structure to normal fetal AM. This study provides the first line of evidence that a compacted
collagen gel containing hASFs could adequately support hAESCs adhesion and differentiation to a degree that is
comparable to the normal human fetal AM in terms of structure and maintenance of cell phenotype.
Introduction
The leading cause of perinatal and neonatal mortality ispreterm birth, of which 40% is attributed to the preterm
premature rupture of the membranes (pPROM).1,2 pPROM
occurs commonly when there is preterm funneling of the
cervix with associated cervical dilation. Preventive therapies
such as progesterone or cervical cerclage are available for
women at high risk of preterm birth,3 but most preterm de-
liveries occur in women considered to be at low risk. Inter-
ventions during pregnancy such as amniocentesis or chorionic
villus sampling and fetoscopy, in particular, are associated
with a high incidence of pPROM due to disruption to the
integrity of the fetal amniotic membrane (AM) at the insertion
site of the fetoscope.4 A number of techniques such as plug-
ging the insertion site with a silicon seal or with platelets have
been developed to seal off the membrane defect after fetos-
copy, but none have proved to be of much benefit.5
AM consists of a single layer of epithelial cells on a thick
basement membrane that lies upon layers of collagenous
tissue interspersed with mesenchymal cells. Interstitial col-
lagens (mostly type I) predominate and maintain the me-
chanical integrity of the AM.6 Cells from the human AM are
of great interest as a source of cells for regenerative medicine
because of their phenotypic plasticity.7,8 Evidence in support
of human amniotic epithelial cell (hAEC) pluripotency in-
cludes work by Sakuragawa et al., who identified neural and
glial markers on cultured hAECs.9 Later studies reported
that cultured hAECs synthesize and release acetylcholine,
catecholamines,10–12 and dopamine.13,14 Hepatic differentia-
tion of hAECs was also reported.15 Alongside the plasticity
of these cells, another advantage in the use of placental tissue
for regenerative medicine is that it is readily available and
easily procured without invasive procedures, and its use
does not elicit ethics debate, avoiding the current contro-
versies associated with the use of human embryonic stem
cells.16 These advantages have been put to effect previously,
and isolated AM epithelial cells, keratinocytes, fibroblasts,
and lung carcinoma cells have each been successfully ex-
panded on the surface of substrates formed from decel-
lularized AM17–19 or polyesterurethane.20 However, the aim
of this study was to construct an artificial AM by combination
of hAESCs and a compacted collagen scaffold that actually
contained human amniotic stromal fibroblasts (hASFs),
thereby closely mimicking the natural AM physiology. This
artificial AMmay have the potential to plug defects in the AM
after antenatal interventions, or to prevent pPROM when
there is funneling and dilatation of the cervix.
Materials and Methods
Isolation and enrichment of hAESCs
The placenta and fetal membranes (FMs) were collected
under sterile conditions from healthy donor pregnant
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women undergoing delivery by elective term caesarean
section at University College London Hospital (UCLH),
United Kingdom (n= 8). All donors gave written informed
consent before tissue collection. This study was approved by
the Joint University College London/UCLH Committees on
the Ethics of Human Research. The amnion layer was pre-
pared according to the methods previously described by
Akle et al.21,22 Amniotic and chorionic tissues were separated
manually by blunt dissection and were washed briefly sev-
eral times with chilled phosphate-buffered saline (PBS)
without calcium and magnesium to remove blood. To release
epithelial cells, the amnion membrane was incubated at 37C
with 0.05% trypsin (Invitrogen). The cells from the first
30min of digestion were discarded to exclude debris. The
cells from the second and third 30-min digests were pooled
and washed three times with PBS. Cells collected by filtration
(70 mm nylon mesh; Fisher brand) and centrifugation at 1500
g for 5min were designated as hAECs.
Magnetic-activated cell sorting (MACS) was used to en-
rich the hAESCs by positive selection of ATP-binding cas-
sette G2 (ABCG2), a marker of hAESCs.22,23 In brief, after
calculating the total epithelial cell number, the cells were
incubated overnight at 4C with primary antibody against
ABCG2 (1:100; Millipore). The cells were then labeled with
anti-mouse IgG microbeads (Miltenyi Biotec), washed again,
and then applied as a cell suspension to a magnetic separator
(Miltenyi Biotec). Isolated ABCG2-positive cells were desig-
nated as hAESCs, and subsequently used in all cell culture
experiments. To assay the clone-forming efficiency, the
ABCG2-positive cells and ABCG2-negative cells were seeded
in a six-well plate at a density of 5000 cells/well. After 5 days
of growth, cells were fixed in methanol for 15min at room
temperature and then stained with Giemsa for 30min, wa-
shed with distilled water, and air-dried, before examining
under an inverted microscope.
Isolation of hASFs
After removal of epithelial cells, the denuded AM (dAM)
was subjected to a full mechanical and enzymatic diges-
tion.24 Pieces of dAM were gently minced in a controlled
fashion by automated tissue dissociation (Miltenyi Biotec)
and were subjected to enzymatic digestion using 0.25%
trypsin–EDTA and 0.1% type I collagenase in Dulbecco’s
modified Eagle’s medium (DMEM; Invitrogen) for 45min at
37C on a rotator until digestion was complete. The super-
natant was neutralized with 5% fetal bovine serum (FBS;
Sigma-Aldrich) in DMEM. The cells were centrifuged and
then re-suspended in DMEM with 10% FBS in a humidified
5% CO2 incubator at 37C until they were 70% confluent
using a 75 cm2 tissue culture flask (Fisher). The expanded
cells were collected and designated as hASFs.
Expansion of hAESCs on differently coated compacted
collagen scaffolds embedded with amniotic
stromal fibroblasts
Collagen gels were made as described previously25 with
some modifications. Briefly, collagen gels were prepared by
1M sodium hydroxide (Fisher) neutralization of 4mL of
sterile rat-tail type I collagen (2.05mg/mL; First Link) mixed
with 0.5mL of 10 · minimum essential medium (Invitrogen).
After neutralization, 0.5mL of media containing hASFs was
added at a concentration of 2.0 · 105 cells/mL, and the so-
lution was gently mixed together and left on ice for 30min
before casting to prevent gelling while allowing dispersion of
any small bubbles within the solution. The gel was cast into
rectangular molds (33mm · 21mm · 8mm) and set at 37C,
0.5% CO2 for 30min. After the initial setting of the gels, they
were then subsequently compacted by a combination of
compression and dehydration. Each gel was sandwiched
between layers of nylon and metal mesh and was then
compressed by applying a weight of 120 g for 5min at room
temperature, leading to the formation of a flat collagen sheet
embedded with viable hASFs. The largest pore size (gaps
between collagen fibers) between compressed collagen gel
and dAM were analyzed by Axiovision Rel.4.8 software
(Carl Zeiss Microimaging).
The resulting compacted collagen gels were then trans-
ferred into six-well plates (transwells; Costar) and each gel
was coated with fibronectin (2.5 mg/cm2; Sigma-Aldrich),
collagen IV (8 mg/cm2; Sigma-Aldrich), laminin (1.5 mg/cm2;
Sigma-Aldrich), or fibronectin/laminin (1:1; Sigma-Aldrich),
which were diluted with PBS, respectively. The scaffolds
were incubated at 37C for 2 h and washed three times with
PBS. MACS-enriched hAESCs were then plated on the dif-
ferently coated collagen gels within a 24-mm-diameter
transwell at a density of 1 · 106 cells per cm2 in our standard
culture medium (DMEM supplemented with 10% FBS,
10 ng/mL epidermal growth factor, 2mM L-glutamine, 1%
nonessential amino acid, 1mM sodium pyruvate, and 1%
antibiotic–antimycotic; all from Invitrogen). The cell attach-
ment efficiency was measured on the differently coated col-
lagen scaffolds. Cells were allowed to attach to the scaffolds
overnight, and before the first round of cell division, the
unattached cells were collected by gentle washing and
counted using a hemocytometer. The cell attachment effi-
ciency was calculated as the number of attached cells re-
maining as compared with the total number of cells
originally plated on the scaffold.
Rheology of scaffolds
The mechanical properties of compacted collagen gels
(with encapsulated hASFs) and dAMwere compared using a
controlled stress AR-2000 rheometer (TA Instruments). A
cone-and-plate geometry (cone diameter 20mm, angle 1)
was used for all samples. Preliminary oscillatory stress
sweeps were performed at a fixed frequency of 1Hz between
0.1 and 100 Pa at 37C to ensure that the moduli were in-
dependent of stress. After this, frequency sweeps were per-
formed with the machine in oscillatory mode at an angular
frequency range (x) of 0.1–100 rad/s under a controlled
stress of 5 Pa.
Electron microscopy
dAM, compacted collagen gel with embedded hASFs,
normal AM, and our fully constructed artificial AM were
examined by scanning electron microscopy (SEM). The nor-
mal AM and constructed artificial AM were examined by
transmission electron microscopy (TEM). Specimens were
fixed in 2.5% (v/v) glutaraldehyde, and postfixed for 2 h
in 1% aqueous osmium tetroxide. They were then washed
with distilled water before being passed through a graded
ethanol series. For SEM, specimens were transferred to
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hexamethyldisilazane for 20min and allowed to air-dry.
These specimens were then mounted on aluminum stubs and
sputter coated with gold before examination using an SEM
(FEI Quanta FEG 600). For TEM, the dehydrated specimens
were embedded in epoxy resin (Agar 100; Agar Scientific,
Ltd.). Ultrathin (70 nm) sections were collected on copper
grids and stained for 1 h with uranyl acetate and 1% phos-
photungstic acid, and then for 20min with Reynolds’ lead
citrate before examination using a transmission electron
microscope (Philips CM20).
Hematoxylin and eosin staining
Normal AM and our fully constructed artificial AM were
examined by hematoxylin and eosin (H&E) staining. Cryo-
sections (5 mm thick) were routinely processed and examined
by light microscopy after H&E staining.
Immunohistochemistry
Normal AM and the artificial AM were examined by im-
munofluorescence. Both tissues were treated with 1% bovine
serum albumin in 50mM Tris-buffered saline (pH 7.2), con-
taining 0.4% Triton X-100 for 60min at room temperature.
Samples were then incubated overnight at 4C with primary
antibodies against ABCG2 (1:100; Millipore) and cytokeratin
19 (CK19, 1:100; Millipore). FITC-labeled secondary anti-
bodies (1:100; Vector Laboratories, Inc.) were used. Samples
were costained with propidium iodide (Vector Laboratories,
Inc.) and observed by fluorescence microscopy (Carl Zeiss
Meditec).
Statistical analysis
A Student’s t-test (unpaired) was performed to compare
rheology results using Microsoft Excel. Results are presented
as the mean of three individual experiments with standard
error of mean and p< 0.05 was considered significant.
Results
Morphology of artificial scaffolds
Both the compacted collagen gel with embedded hASFs
and dAM had similar translucency; however, the compacted
collagen gel appeared more homogeneous (Fig. 1A) than the
dAM (Fig. 1B). The SEM analyses demonstrated that the
collagen fibers within the compacted collagen gel appeared
dense with fiber diameter and fiber arrangement similar to
the dAM (Fig. 1C, D). Comparing the relative pore sizes
(gaps between collagen fibers), the compressed gel was
similar to the dAM. When comparing surface areas of ap-
proximately 6000 mm2 between the compressed scaffold and
dAM (control), the largest pore sizes were determined to be
672 and 659 nm, respectively, indicating similar pore sizes
(Fig. 1C, D).
Rheology of scaffolds
Oscillatory shear rheology was used to probe the dynamic
mechanical properties of compacted collagen gel and dAM,
where G¢ (storage modulus) and G¢¢ (loss modulus) refer to
the stiffness and viscoelastic properties of the materials.
Stress sweeps indicated that the compacted collagen gel had
FIG. 1. (A) Compacted





microscopy (SEM) of (C)
compacted collagen scaffold
surface and (D) dAM surface.
Scale bar (A, B) 5mm and (C,
D) 10mm.
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a longer linear regime than dAM and can withstand shearing
at high stresses up to 25 Pa (Fig. 2A, n= 3). Based on pre-
liminary stress sweeps, a fixed stress of 5 Pa was selected for
frequency sweep studies corresponding to stresses within the
linear viscoelastic regime of both of our materials. Figure 2B
showed the frequency sweep data for further characteriza-
tion of the structure of our scaffolds (n= 3). Both materials
behaved as stiff gels with compacted collagen gel G¢
(2000 – 51.67 Pa) > 103 and dAM G¢ (220 – 101.39 Pa) > 102 at
low frequencies. This indicated that compacted collagen gel
is the stiffer of the two materials over a range of frequencies
where G¢ remains constant ( p< 0.05). The dynamic mechan-
ical properties of both scaffolds appeared to demonstrate
behavior of weak frequency dependence. In addition, values
for G¢ are larger than G¢¢ by a factor of 5–10 for both scaf-
folds, indicating an ordered structure.
MACS of amniotic epithelial cells
ABCG2 is recognized as a stem cell marker for hAESCs.22,23
Expression of ABCG2 in primary hAESCs was evaluated by
MACS using anti-ABCG2 micro-beads. ABCG2-positive cells
accounted for 14% (n=2) of the cells in the primary hAEC
population. A representative experiment is shown in Figure
3A and B. Colony-forming efficiency (CFE) was used to ana-
lyze the proliferation of the ABCG2-positive and -negative cell
groups. The result indicated that the CFE of the ABCG2-
positive group was demonstrably higher than that of the
negative group (Fig. 3C, D).
Amniotic epithelial stem cells grown on coated
compacted collagen gels with embedded hASFs
The hAESCs were cultured on noncoated (Fig. 4A), colla-
gen IV (Fig. 4B), fibronectin (Fig. 4C), laminin (Fig. 4D), and
fibronectin/laminin (1:1, Fig. 4E)-coated compacted collagen
gels for 12h, and the cell attachment efficiencies were found
to be 17%, 61%, 69%, 66%, and 100%, respectively (n=5).
The cells formed a continuous monolayer on the fibronectin/
laminin (1:1)-coated collagen gel with a resulting ultrastruc-
ture similar to the normal AM control (Fig. 4F).
Morphology of hAESCs expanded upon compacted
collagen gels with embedded hASFs
The morphology of hAESCs on fibronectin/laminin (1:1)-
coated compacted collagen gel containing hASFs was stud-
ied on day 5 after high-density cell seeding. hAESCs
exhibited a typical polygon-type cell shape with plenty of
microvilli on the cell surface and formed a continuous
monolayer on the compacted collagen gel (Fig. 5A) similar to
normal AM (Fig. 5B).
H&E staining
Histological analysis using H&E staining showed that the
tissue-engineered sheet formed a single continuous epithelial
cell layer on the compacted collagen gel (Fig. 6A). This is
similar to the epithelial structure of native AM (Fig. 6B). The
hASFs that were encapsulated in the collagen scaffolds had a
similar cell distribution pattern and cell density to the normal
AM stroma, and the thickness of the artificial AM was also
similar to the normal AM.
FIG. 2. The rheological
properties of compacted
collagen containing hASFs and
dAM also containing native
hASFs (n=3). Preliminary os-
cillatory stress sweeps carried
out at 37C (A). Oscillatory
frequency sweeps carried out
at 37C at a controlled stress of
5 Pa for both scaffolds. Closed
and open circles refer to G¢
(storagemodulus) andG¢¢ (loss
modulus), respectively (B).
Color images available online
at www.liebertonline.com/tea
FIG. 3. Magnetically activated cell sorting to enrich human
amniotic epithelial stem cells (hAESCs) (A). ABCG2-negative
cells flow through the column and ABCG2-positive cells
adhered on the column. The ABCG2-positive cells were flu-
shed out by firmly pushing the plunger into the column
after removing the magnets (B). The colony-forming efficiency
of ABCG2-positive cell group (C) and ABCG2-negative cell
group (D). Color images available online at www.liebert
online.com/tea
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Transmission electron microscopy
TEM analyses indicated that the hAESCs expanded upon
the compacted collagen gel had produced a defined base-
ment membrane with evidence of hemidesmosome forma-
tion on the basal side (Fig. 7A), and neighboring cells were
attached via desmosome structures (Fig. 7B).
Immunohistochemistry
After culture for 5 days, the hAESCs were distributed
evenly on the scaffold and formed a monolayer. ABCG2, a
marker of hAESCs,22,23 was expressed in the membrane of
cells from both artificial AM (Fig. 8A–C) and normal AM
(Fig. 8G–I). Another hAESC marker, CK19, was expressed in
the cytoplasm of epithelial cells from artificial AM (Fig. 8D–
F) and normal AM (Fig. 8 J–L). Compared with the artificial
AM, the normal AM epithelial cells had a higher proportion
of ABCG2- and CK19-positive cells (see the merged color
images [Fig. 8 C, F, I, L] for CK19 [green; Fig. 8B, E, H, K],
and propidium iodide [red; Fig. 8A, D, G, J], respectively].
Discussion
This study demonstrates the successful ex vivo construction
of an FM by combination of human amniotic stem cells and a
compacted collagen gel containing human amniotic fibro-
blasts. The resulting cellular–collagen construct displays many
of the structural and functional properties of human AM.
The hAESCs represent an important source of cells with
pluripotential characteristics.22,26 Preclinical and clinical
FIG. 4. hAESCs cultured on noncoated (A), collagen IV-coated (B), fibronectin-coated (C), laminin-coated (D), and fibro-
nectin/laminin (1:1)-coated (E) compressed gels. (F) normal AM. Scale bar= 50mm.




scaffold (A). Control normal
human AM epithelial cells
(B). Scale bar = 20mm.
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studies have demonstrated high proliferation ability and
multiple uses for hAESCs in tissue repair, such as corneal
tissue,27 spinal cord injury,28 brain infarction,10 and Parkin-
son’s disease.14 In this study, we used a MACS method to
enrich the hAESCs by positive selection of ABCG2,22,23 the
CFE of ABCG2-positive cells was much higher than that of
ABCG2-negative cells, indicating that the enriched positive
cells have strong proliferative ability, one common property
of stem cells.
Cell adhesion to a material is mediated primarily by the
interaction between surface bound proteins and the corre-
sponding receptors on the cell membrane.29 Extensive re-
search on the cellular response to different proteins
preadsorbed onto various surfaces, including collagen,30,31
laminin,32,33 and fibronectin,34,35 indicates that synthetic
materials must adsorb proteins to improve their interaction
with cells.36–38 Amniotic epithelial cells are easily detached
from the amniotic stroma to float in the amniotic fluid.
Therefore, in this study, we investigated the adhesion and
growth of primary hAESCs on compacted collagen gels
coated with collagen IV, fibronectin, or laminin to improve
epithelial cell adhesion and spreading. Our results showed
that substrate surfaces coated with collagen IV, laminin, or
fibrnoectin did not achieve hAESC confluence; nevertheless,
growth was significantly enhanced compared to hAESCs cul-
tured on a plain collagen type I surface. Importantly, however,
hAESCs cultured on a combined laminin/fibronectin (1:1)-
coated surface were able to grow to confluence, producing a
tissue very similar in structure to the normal AM. The reason
for this may be that the presence of the two kinds of coated
proteins (laminin/fibronectin) increased surface-bound
protein expression in response to corresponding cell recep-
tors, and once the cells adhere, they generated their own
extracellular matrix, creating an optimal environment for
their survival.39
Although we were successful in maintaining a population
of ABCG2-positive hAESCs on the compressed collagen gel
ex vivo and that this level may be therapeutically relevant, a
high proportion of cells did appear to lose ABCG2 expres-
sion in culture. We believe that this loss may in part be ex-
plained by the higher stiffness of the collagen gel compared
to AM. Recently, several notable studies have demonstrated
the importance of substrate stiffness in the regulation of stem
cell differentiation.40–42 Further, we have recently shown that
a variation in either AM or compressed collagen gel stiffness
could dramatically influence the differentiation of unipotent
stem cells.43,44 We believe that we are seeing the same phe-
nomenon with hAESCs. However, in terms of its intended
function, the creation of an artificial AM with a greater
ability to store applied mechanical energy is also likely to be
important.
We improved the mechanical properties of conventional
collagen gels by compaction, resulting in a dense and me-
chanically strong collagen scaffold.45 Similar to the results
attained using compacted collagen gels containing corneal
fibroblasts,46 dehydration of the collagen gel maintained the
viability of the encapsulated hASFs.46 The SEM analyses
demonstrated that the collagen fibers within the compacted
gel appeared dense and homogeneous, and the fiber’s dia-
meter, arrangement, and the gel’s relative pore size were
similar to normal dAM. Subsequently, we successfully used
this hASF-embedded, laminin/fibronectin (1:1)-coated com-
pacted collagen gel as a novel substrate/scaffold to support
the adherence and expansion of hAESCs—that is, a tissue-
engineered human FM.
To achieve lasting closure of FM lesions, biomaterials
are required that permit not only instant sealing of the
FIG. 6. Hematoxylin and eosin staining of tissue-
engineered human AM (A) and normal (native) human AM
(B). Scale bar = 50mm. Color images available online at
www.liebertonline.com/tea
FIG. 7. Transmission electron microscopy images of tissue
engineering AM and normal AM. (A) Basal cells appeared to
adhere well to the compressed collagen scaffold via hemi-
desmosome attachments (arrows). (B) Neighboring cells
displayed desmosome junctions (arrows). (C) Hemidesmo-
some attachments in normal AM (arrows). (D) Desmosome
junctions in normal AM (arrows). Scale bars= 1mm.
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membrane leak but also subsequent anatomical repair of the
lesion through recruited amnion cells. In the current study,
we were able to replace decellularized AM with a finely
regulated collagen gel that uniquely contained amniotic fi-
broblasts encapsulated within it. Using this engineered
stroma, we explored whether the structural and functional
properties required of the AM could be replicated and
maintained by our tissue-engineered AM. In terms of the
artificial AM for clinical use, possibly safety concerns could
be addressed by replacing rat tail collagen with bovine (for
which there is food and drug administration approval) or
less-immunogenic sources of collagen such as collagen ex-
tracted from human placenta or recombinant human type I
collagen. Our results showed that under culture conditions
without other cell-derived feeder layers, hAESCs adhered to
fibronectin-laminin (1:1)-coated compacted collagen scaffold,
exhibiting a typical polygon-type cell shape with plenty of
microvilli forming a confluent monolayer after culture for 1
week. Further, immunophenotypic characterization of
hAESCs demonstrated expression of well-defined markers
of hAESCs, that is, ABCG222,23 and CK19. H&E staining
showed that both epithelial cells and stromal cells within the
artificial AM had a similar cell distribution pattern, cell
density, and thickness to normal AM.47 The TEM images
revealed that epithelial cells of artificial AM connected with
collagen scaffold through hemidesmosome attachments and
formed basal membrane, and the epithelial cells connected
each other through desmosomes similar to normal AM.
Conclusions
This is the first study to describe the bottom up manu-
facture of a tissue-engineered FM using totally discrete
components that significantly allow for the encapsulation
of hASFs. Specifically, a combination of hAESCs and a
fibronectin-laminin (1:1)-coated compacted collagen scaffold
FIG. 8. Immunofluorescent staining for the hAESC markers ABCG2, CK19, and propidium iodide costained nuclei. Artificial
AM stained for ABCG2 [see the merged color images (C) for ABCG2 (green; B) and propidium iodide (red; A)] and CK19 [see
the merged color images (I) for CK19 (green;H) and propidium iodide (red; G)]. Normal AM-stained ABCG2 [see the merged
color images (F) for ABCG2 (green; E) and propidium iodide (red; D)] and CK19 [see the merged color images (L) for CK19
(green; K) and propidium iodide (red; J)]. Scale bar= 50mm. Color images available online at www.liebertonline.com/tea
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containing hASFs was constructed ex vivo. The collagen
scaffold was found to support the attachment of hAESCs and
differentiation into amniotic epithelial cells. The artificial AM
retained structural and functional properties similar to nor-
mal AM, and this human tissue construct may become a
useful means to repair iatrogenic defects in the FMs or cases
of pPROMs.
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